Carlos Campoy
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carlos Campoy
Earlier roles on record: CFO at CytomX Therapeutics, Inc. (CTMX) until September 30, 2022. CytomX Therapeutics, Inc. reported in an 8-K filed September 23, 2022 that Carlos Campoy was terminated as SVP, Chief Financial Officer, effective September 30, 2022. The proxy statement of CytomX Therapeutics, Inc. reports total compensation of $1,420,271 for Carlos Campoy in fiscal 2022, including a base salary of $349,479. Disclosed compensation is on record for 5 fiscal years. Carlos Campoy has spoken on 9 earnings calls across 1 company, most recently for CytomX Therapeutics, Inc. on August 4, 2022.
“in connection to the planned departure of Carlos Campoy, the Company's SVP, Chief Financial Officer and former principal financial officer and principal accounting officer, whose employment is expected to terminate effective as of September 30, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-03-23–2022-09-30
-
Start not stated–2022-09-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | CytomX Therapeutics, Inc. (CTMX) | Former Senior Vice President and Chief Financial Officer | $349,479 | $1,420,271 |
| 2021 | CytomX Therapeutics, Inc. (CTMX) | Former Senior Vice President and Chief Financial Officer | $477,555 | $1,396,204 |
| 2020 | CytomX Therapeutics, Inc. (CTMX) | Senior Vice President, Chief Financial Officer | $360,052 | $1,741,639 |
| 2019 | CytomX Therapeutics, Inc. (CTMX) | Senior Vice President, Chief Financial Officer | — | — |
| 2018 | CytomX Therapeutics, Inc. (CTMX) | Senior Vice President, Chief Financial Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.